miRNA-1231 Regulated EGFR Signaling: A Potential Therapeutic Target for Hepatocellular Carcinoma
- 2 February 2026
- journal article
- research article
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 198 (4) , 2793-2805
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Biomarkers for diagnosis and therapeutic options in hepatocellular carcinomaMolecular Cancer, 2024
- MDM2: current research status and prospects of tumor treatmentCancer Cell International, 2024
- A LIGHTFUL nanomedicine overcomes EGFR-mediated drug resistance for enhanced tyrosine-kinase-inhibitor-based hepatocellular carcinoma therapyBiomaterials, 2023
- Effects and Mechanism of Oxymatrine Combined with Compound Yinchen Granules on the Apoptosis of Hepatocytes through the Akt/FoxO3a/Bim PathwayBioMed Research International, 2022
- MicroRNAs involved in the EGFR pathway in glioblastomaBiomedicine & Pharmacotherapy, 2021
- Signaling pathways in hepatocellular carcinoma2021
- NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinomaCell Death & Disease, 2020
- Regulation of PERK expression by FOXO3: a vulnerability of drug-resistant cancer cellsOncogene, 2019
- Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinomaRoyal Society Open Science, 2018
- miR-302b suppresses cell invasion and metastasis by directly targeting AKT2 in human hepatocellular carcinoma cellsTumor Biology, 2015